Dietary guidance and probiotics for pelvic pain in women with endometriosis and IBS
Official title: Impact of Dietary Guidance and Probiotics in the Treatment of Chronic Pelvic Pain Secondary to Endometriosis and Irritable Bowel Syndrome in Women: A Randomized, Double-Blind Clinical Trial
Run by University of Sao Paulo · NCT07149519 · Data updated 2026-11-12
This trial will try dietary guidance and Lactobacillus probiotics to see if they reduce chronic pelvic pain in women who have both endometriosis and irritable bowel syndrome.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 50 Years |
| Sex | Women only |
| Enrollment | 74 (estimated) |
| Sponsor | University of Sao Paulo Academic / other |
| Locations | 1 site (Catanduva, São Paulo) |
| Status | Recruiting |
| Started | March 1, 2025 |
| Main results expected | June 30, 2028 |
| Study ends | February 15, 2029 |
| Registry record updated | September 2, 2025 |
| Trial ID | NCT07149519 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18–50 with diagnosed endometriosis and concurrent irritable bowel syndrome who can give informed consent and agree to be randomized and participate exclusively during the study period are ideal candidates.
✕Probably not a fit
Women with severe or uncontrolled chronic medical conditions, or with other gastrointestinal diseases such as inflammatory bowel disease or celiac disease, and those outside the 18–50 age range are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Participants with endometriosis and coexisting irritable bowel syndrome will be randomized to different intervention arms that include dietary guidance and use of Lactobacillus probiotics. The study will follow participants over a treatment period to record changes in chronic pelvic pain and bowel symptoms. Investigators will compare symptom scores between the groups to determine whether non‑pharmacological approaches relieve pain and improve bowel habits. The trial aims to clarify the role of diet and gut microbiota modulation in managing these overlapping conditions.
Why it matters
Potential benefit: If successful, the interventions could reduce chronic pelvic pain and improve bowel symptoms and quality of life using non‑drug approaches.
How similar studies have gone: Previous studies of anti‑inflammatory diets and some probiotic trials have reported symptom improvements in endometriosis and IBS, but evidence is mixed and larger randomized trials remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Women between 18 and 50 years of age who wish to participate in the clinical trial; 2. Willingness to voluntarily participate in the study and accept randomization to any of the three treatment arms; 3. Participating exclusively in this clinical trial during the study period; 4. Signing the Informed Consent Form (ICF) approved by the Research Ethics Committee (CEP) and CONEP Exclusion Criteria: 1. Chronic, severe, or uncompensated clinical conditions, such as: malnutrition (BMI \<18); insulin-dependent diabetes (types 1 or 2); uncontrolled hypertension; lung disease such as asthma or other chronic obstructive pulmonary disease; hematologic and liver diseases; advanced-stage chronic kidney disease (grades 3, 4, and 5); metabolic disorders; and immunosuppression; 2. Clinical conditions of the gastrointestinal tract that cause IBS-like symptoms, such as: inflammatory bowel disease (Chron's disease, ulcerative colitis), microscopic colitis, celiac disease, and lactose intolerance; 3. Endometriosis requiring surgical treatment during the study period; 4. Severe eating disorders, such as: bulimia, anorexia nervosa, and binge-eating disorder; 5. Chronic use of any medication with potential interaction with probiotics, the intestinal microbiota, or the natural progression of the disease in the last 6 months (such as probiotics, antibiotics, antifungals, antihistamines, digestive medications, or treatments for constipation or diarrhea); 6. Patients who already consume healthy foods or are on a restrictive diet more than four days a week, which may affect the evaluation results; 7. Patients whose stool protopastological examination is altered; 8. Inability to use oral medication; 9. Pregnancy or lactation; 10. History of alcohol or drug dependence; 11. Smoking in the last three years; 12. Inability to cooperate with investigators due to cognitive impairment or mental state.
Where it's running
-
Letícia Ferracini Lenharo Hayashi
Catanduva, São Paulo, Brazil Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing different techniques to treat endometriosis
This study is testing different methods to treat endometriosis, like laser and heat techniques, to see which one works best for relieving pain in women who are already having surgery for the condition.
-
Postoperative Pain Trajectories After Endometriosis Surgery
This study tests how pain changes after endometriosis surgery and whether perioperative pain testing can predict who will have ongoing pain.
-
Imaging endometriosis with a special PET tracer in adult women
This study tests whether a PET/CT scan using [18F]AlF-FAPI-74 can help detect endometriosis lesions in women who are planning laparoscopy.
-
Fiber supplement for digestive symptoms in endometriosis
A fiber-based supplement is being tested to see if it is safe and helps with gut and vaginal microbiomes and digestive symptoms in women with endometriosis.
-
Stellate ganglion block and dexmedetomidine for better sleep after gynecologic laparoscopy
The study tests whether giving a preoperative stellate ganglion block plus intraoperative dexmedetomidine improves sleep after laparoscopic gynecologic surgery in women.
-
Atypical Endometriosis: Histology, Immunophenotype and Molecular Features
Researchers will look at how endometriotic tissue that looks atypical under the microscope relates to clinical features and ultrasound findings to better separate benign from potentially atypical lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.